<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35523788</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2041-4889</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cell death &amp; disease</Title>
          <ISOAbbreviation>Cell Death Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Glutathione prevents high glucose-induced pancreatic fibrosis by suppressing pancreatic stellate cell activation via the ROS/TGFβ/SMAD pathway.</ArticleTitle>
        <Pagination>
          <StartPage>440</StartPage>
          <MedlinePgn>440</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">440</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-022-04894-7</ELocationID>
        <Abstract>
          <AbstractText>The activation of pancreatic stellate cells (PSCs) is the key mechanism of pancreatic fibrosis, which can lead to β-cell failure. Oxidative stress is an important risk factor for PSC activation. There is no direct evidence proving if administration of glutathione can inhibit fibrosis and β-cell failure. To explore the role of glutathione in pancreatic fibrosis and β-cell failure induced by hyperglycaemia, we established a rat model of pancreatic fibrosis and β-cell failure. The model was founded through long-term oscillating glucose (LOsG) intake and the setup of a sham group and a glutathione intervention group. In vitro, rat PSCs were treated with low glucose, high glucose, or high glucose plus glutathione to explore the mechanism of high glucose-induced PSC activation and the downstream effects of glutathione. Compared with sham rats, LOsG-treated rats had higher reactive oxygen species (ROS) levels in peripheral leukocytes and pancreatic tissue while TGFβ signalling was upregulated. In addition, as the number of PSCs and pancreatic fibrosis increased, β-cell function was significantly impaired. Glutathione evidently inhibited the upregulation of TGFβ signalling and several unfavourable outcomes caused by LOsG. In vitro treatment of high glucose for 72 h resulted in higher ROS accumulation and potentiated TGFβ pathway activation in PSCs. PSCs showed myofibroblast phenotype transformation with upregulation of α-SMA expression and increased cell proliferation and migration. Treatment with either glutathione or TGFβ pathway inhibitors alleviated these changes. Together, our findings suggest that glutathione can inhibit PSC activation-induced pancreatic fibrosis via blocking ROS/TGFβ/SMAD signalling in vivo and in vitro.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Zhang</LastName>
            <ForeName>Jitai</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiac Regeneration Research Institute, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Bai</LastName>
            <ForeName>Juan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Qian</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Yuxin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiac Regeneration Research Institute, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Qian</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiac Regeneration Research Institute, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Lanting</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiac Regeneration Research Institute, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Huamin</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>An</LastName>
            <ForeName>Hui</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiac Regeneration Research Institute, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesia and Critical Care, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Chuanzan</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiac Regeneration Research Institute, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yongyu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiac Regeneration Research Institute, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Xiufang</ForeName>
            <Initials>X</Initials>
            <Identifier Source="ORCID">0000-0002-8795-6923</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China. chxiufang@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Ming</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-7699-4502</Identifier>
            <AffiliationInfo>
              <Affiliation>Cardiac Regeneration Research Institute, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China. mingli@wmu.edu.cn.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. mingli@wmu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cell Death Dis</MedlineTA>
        <NlmUniqueID>101524092</NlmUniqueID>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>GAN16C9B8O</RegistryNumber>
          <NameOfSubstance UI="D005978">Glutathione</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>IY9XDZ35W2</RegistryNumber>
          <NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005978" MajorTopicYN="N">Glutathione</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058954" MajorTopicYN="Y">Pancreatic Stellate Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016212" MajorTopicYN="Y">Transforming Growth Factor beta</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>23</Hour>
          <Minute>16</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35523788</ArticleId>
        <ArticleId IdType="pmc">PMC9076672</ArticleId>
        <ArticleId IdType="doi">10.1038/s41419-022-04894-7</ArticleId>
        <ArticleId IdType="pii">10.1038/s41419-022-04894-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pr. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diabres.2019.107843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care. 2010;33:2477–83. doi: 10.2337/dc10-1079.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/dc10-1079</ArticleId>
            <ArticleId IdType="pmc">PMC2963518</ArticleId>
            <ArticleId IdType="pubmed">20693348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang J, An H, Ni K, Chen B, Li H, Li Y, et al.  Glutathione prevents chronic oscillating glucose intake-induced beta-cell dedifferentiation and failure. Cell Death Dis. 2019;10:321. doi: 10.1038/s41419-019-1552-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-019-1552-y</ArticleId>
            <ArticleId IdType="pmc">PMC6459929</ArticleId>
            <ArticleId IdType="pubmed">30975975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayden MR. Islet amyloid and fibrosis in the cardiometabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr. 2007;2:70–75. doi: 10.1111/j.1559-4564.2007.06159.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1559-4564.2007.06159.x</ArticleId>
            <ArticleId IdType="pubmed">17684452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Homo-Delarche F, Calderari S, Irminger JC, Gangnerau MN, Coulaud J, Rickenbach K, et al.  Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat. Diabetes. 2006;55:1625–33. doi: 10.2337/db05-1526.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db05-1526</ArticleId>
            <ArticleId IdType="pubmed">16731824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho JH, Kim JW, Shin JA, Shin J, Yoon KH. β-cell mass in people with type 2 diabetes. J Diabetes Investig. 2011;2:6–17. doi: 10.1111/j.2040-1124.2010.00072.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.2040-1124.2010.00072.x</ArticleId>
            <ArticleId IdType="pmc">PMC4008010</ArticleId>
            <ArticleId IdType="pubmed">24843456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim JW, Ko SH, Cho JH, Sun C, Hong OK, Lee SH, et al.  Loss of beta-cells with fibrotic islet destruction in type 2 diabetes mellitus. Front Biosci. 2008;13:6022–33. doi: 10.2741/3133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2741/3133</ArticleId>
            <ArticleId IdType="pubmed">18508639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donath MY, Boni-Schnetzler M, Ellingsgaard H, Ehses JA. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. Physiology. 2009;24:325–31. doi: 10.1152/physiol.00032.2009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physiol.00032.2009</ArticleId>
            <ArticleId IdType="pubmed">19996363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferdek PE, Jakubowska MA. Biology of pancreatic stellate cells-more than just pancreatic cancer. Pflug Arch. 2017;469:1039–50. doi: 10.1007/s00424-017-1968-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00424-017-1968-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Norris AW, Ode KL, Merjaneh L, Sanda S, Yi Y, Sun X, et al.  Survival in a bad neighborhood: pancreatic islets in cystic fibrosis in cystic fibrosis. J Endocrinol. 2019;241:JOE18–0468. doi: 10.1530/JOE-18-0468.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/JOE-18-0468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bynigeri RR, Jakkampudi A, Jangala R, Subramanyam C, Sasikala M, Rao GV, et al.  Pancreatic stellate cell: Pandora’s box for pancreatic disease biology. World J Gastroenterol. 2017;23:382–405. doi: 10.3748/wjg.v23.i3.382.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v23.i3.382</ArticleId>
            <ArticleId IdType="pmc">PMC5291844</ArticleId>
            <ArticleId IdType="pubmed">28210075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee E, Ryu GR, Ko SH, Ahn YB, Song KH. A role of pancreatic stellate cells in islet fibrosis and beta-cell dysfunction in type 2 diabetes mellitus. Biochem Biophys Res Commun. 2017;485:328–34. doi: 10.1016/j.bbrc.2017.02.082.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2017.02.082</ArticleId>
            <ArticleId IdType="pubmed">28232184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zang G, Sandberg M, Carlsson PO, Welsh N, Jansson L, Barbu A. Activated pancreatic stellate cells can impair pancreatic islet function in mice. Upsala J Med Sci. 2015;120:169–80. doi: 10.3109/03009734.2015.1032453.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/03009734.2015.1032453</ArticleId>
            <ArticleId IdType="pmc">PMC4526872</ArticleId>
            <ArticleId IdType="pubmed">25854824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu M, Cai J, Wei H, Zhou M, Xu P, Huang H, et al.  Scoparone protects against pancreatic fibrosis via TGF-β/Smad signaling in rats. Cell Physiol Biochem. 2016;40:277–86. doi: 10.1159/000452544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000452544</ArticleId>
            <ArticleId IdType="pubmed">27855406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsang SW, Zhang HJ, Chen YG, Auyeung KK, Bian ZX. Eruberin A, a natural flavanol glycoside, exerts anti-fibrotic action on pancreatic stellate cells. Cell Physiol Biochem. 2015;36:2433–46. doi: 10.1159/000430204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000430204</ArticleId>
            <ArticleId IdType="pubmed">26279445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang F, Liao Z, Hu LH, Du YQ, Man XH, Gu JJ, et al.  Comparison of antioxidative and antifibrotic effects of alpha-tocopherol with those of tocotrienol-rich fraction in a rat model of chronic pancreatitis. Pancreas. 2011;40:1091–6. doi: 10.1097/MPA.0b013e31821b59c6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPA.0b013e31821b59c6</ArticleId>
            <ArticleId IdType="pubmed">21926544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr. 2004;134:489–92. doi: 10.1093/jn/134.3.489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jn/134.3.489</ArticleId>
            <ArticleId IdType="pubmed">14988435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lutchmansingh FK, Hsu JW, Bennett FI, Badaloo AV, McFarlane-Anderson N, Gordon-Strachan GM, et al.  Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia. PLoS One. 2018;13:e0198626. doi: 10.1371/journal.pone.0198626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0198626</ArticleId>
            <ArticleId IdType="pmc">PMC5991679</ArticleId>
            <ArticleId IdType="pubmed">29879181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whiting PH, Kalansooriya A, Holbrook I, Haddad F, Jennings PE. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. Br J Biomed Sci. 2008;65:71–74. doi: 10.1080/09674845.2008.11732800.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09674845.2008.11732800</ArticleId>
            <ArticleId IdType="pubmed">19055108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Memisogullari R, Taysi S, Bakan E, Capoglu I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct. 2003;21:291–6. doi: 10.1002/cbf.1025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cbf.1025</ArticleId>
            <ArticleId IdType="pubmed">12910484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian L, Lu Z, Miao Y. Primary cultures for pancreatic stellate cells (PSCs) Methods Mol Biol. 2019;1882:149–55. doi: 10.1007/978-1-4939-8879-2_13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4939-8879-2_13</ArticleId>
            <ArticleId IdType="pubmed">30378051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2–ΔΔCT method. Methods. 2001;25:402–8. doi: 10.1006/meth.2001.1262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId>
            <ArticleId IdType="pubmed">11846609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayden MR, Sowers JR. Isletopathy in Type 2 diabetes mellitus: implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress. Antioxid Redox Signal. 2007;9:891–910. doi: 10.1089/ars.2007.1610.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2007.1610</ArticleId>
            <ArticleId IdType="pubmed">17516840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Restaino RM, Deo SH, Parrish AR, Fadel PJ, Padilla J. Increased monocyte-derived reactive oxygen species in type 2 diabetes: role of endoplasmic reticulum stress. Exp Physiol. 2017;102:139–53. doi: 10.1113/EP085794.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/EP085794</ArticleId>
            <ArticleId IdType="pmc">PMC5600886</ArticleId>
            <ArticleId IdType="pubmed">27859785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kitamura T. The role of FOXO1 in beta-cell failure and type 2 diabetes mellitus. Nat Rev Endocrinol. 2013;9:615–23. doi: 10.1038/nrendo.2013.157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrendo.2013.157</ArticleId>
            <ArticleId IdType="pubmed">23959366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev. 1998;19:477–90. doi: 10.1210/edrv.19.4.0336.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/edrv.19.4.0336</ArticleId>
            <ArticleId IdType="pubmed">9715376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–10. doi: 10.2337/diabetes.52.1.102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.52.1.102</ArticleId>
            <ArticleId IdType="pubmed">12502499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kroemer G, Lopez-Otin C, Madeo F, de Cabo R. Carbotoxicity-noxious effects of carbohydrates. Cell. 2018;175:605–14. doi: 10.1016/j.cell.2018.07.044.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2018.07.044</ArticleId>
            <ArticleId IdType="pmc">PMC6265656</ArticleId>
            <ArticleId IdType="pubmed">30340032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocr Rev. 2008;29:351–66. doi: 10.1210/er.2007-0023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/er.2007-0023</ArticleId>
            <ArticleId IdType="pmc">PMC2528858</ArticleId>
            <ArticleId IdType="pubmed">18048763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janikiewicz J, Hanzelka K, Kozinski K, Kolczynska K, Dobrzyn A. Islet β-cell failure in type 2 diabetes—Within the network of toxic lipids. Biochem Biophys Res Commun. 2015;460:491–6. doi: 10.1016/j.bbrc.2015.03.153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2015.03.153</ArticleId>
            <ArticleId IdType="pubmed">25843796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weir GC, Bonner-Weir S. Five stages of evolving β-cell dysfunction during progression to diabetes. Diabetes. 2004;53:S16–21. doi: 10.2337/diabetes.53.suppl_3.S16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.53.suppl_3.S16</ArticleId>
            <ArticleId IdType="pubmed">15561905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Govindarajan M, Mohan V, Deepa R, Ashok S, Pitchumoni CS. Histopathology and immunohistochemistry of pancreatic islets in fibrocalculous pancreatic diabetes. Diabetes Res Clin Pr. 2001;51:29–38. doi: 10.1016/S0168-8227(00)00204-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0168-8227(00)00204-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ko SH, Kwon HS, Kim SR, Moon SD, Ahn YB, Song KH, et al.  Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats. Biochem Biophys Res Commun. 2004;316:114–22. doi: 10.1016/j.bbrc.2004.02.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2004.02.023</ArticleId>
            <ArticleId IdType="pubmed">15003519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME. Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat. Diabetes. 2004;53:989–97. doi: 10.2337/diabetes.53.4.989.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.53.4.989</ArticleId>
            <ArticleId IdType="pubmed">15047614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saito R, Yamada S, Yamamoto Y, Kodera T, Hara A, Tanaka Y, et al.  Conophylline suppresses pancreatic stellate cells and improves islet fibrosis in Goto-Kakizaki rats. Endocrinology. 2012;153:621–30. doi: 10.1210/en.2011-1767.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2011-1767</ArticleId>
            <ArticleId IdType="pubmed">22202163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim JW, Park SY, You YH, Ham DS, Lee SH, Yang HK, et al.  Suppression of ROS production by exendin-4 in PSC attenuates the high glucose-induced islet fibrosis. PLoS One. 2016;11:e0163187. doi: 10.1371/journal.pone.0163187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0163187</ArticleId>
            <ArticleId IdType="pmc">PMC5157943</ArticleId>
            <ArticleId IdType="pubmed">27977690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ryu GR, Lee E, Chun HJ, Yoon KH, Ko SH, Ahn YB, et al.  Oxidative stress plays a role in high glucose-induced activation of pancreatic stellate cells. Biochem Biophys Res Commun. 2013;439:258–63. doi: 10.1016/j.bbrc.2013.08.046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2013.08.046</ArticleId>
            <ArticleId IdType="pubmed">23973482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sekhar RV, McKay SV, Patel SG, Guthikonda AP, Reddy VT, Balasubramanyam A, et al.  Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care. 2011;34:162–7. doi: 10.2337/dc10-1006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/dc10-1006</ArticleId>
            <ArticleId IdType="pmc">PMC3005481</ArticleId>
            <ArticleId IdType="pubmed">20929994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawson JS, Syme HM, Wheeler-Jones CP, Elliott J. Urinary active transforming growth factor β in feline chronic kidney disease. Vet J. 2016;214:1–6. doi: 10.1016/j.tvjl.2016.02.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tvjl.2016.02.004</ArticleId>
            <ArticleId IdType="pmc">PMC4949776</ArticleId>
            <ArticleId IdType="pubmed">27387717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu M, Zeng X, Wang J, Fu Z, Wang J, Liu M, et al.  Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis. Stem Cell Res Ther. 2016;7:63. doi: 10.1186/s13287-016-0319-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13287-016-0319-y</ArticleId>
            <ArticleId IdType="pmc">PMC4842299</ArticleId>
            <ArticleId IdType="pubmed">27107963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qian ZY, Peng Q, Zhang ZW, Zhou LA, Miao Y. Roles of Smad3 and Smad7 in rat pancreatic stellate cells activated by transforming growth factor-beta 1. Hepatobiliary Pancreat Dis Int. 2010;9:531–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20943464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu M, Wang G, Zhou H, Cai J, Li P, Zhou M, et al.  TGF-β1-miR-200a-PTEN induces epithelial-mesenchymal transition and fibrosis of pancreatic stellate cells. Mol Cell Biochem. 2017;431:161–8. doi: 10.1007/s11010-017-2988-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11010-017-2988-y</ArticleId>
            <ArticleId IdType="pubmed">28281184</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
